Skip to main content
See every side of every news story
Published • loading... • Updated

Insider Buying: Corvus Pharmaceuticals (NASDAQ:CRVS) Insider Acquires 1,003 Shares of Stock

Summary by MarketBeat
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS - Get Free Report) insider Jeffrey Arcara acquired 1,003 shares of the firm's stock in a transaction that occurred on Friday, November 13th. The stock was purchased at an average price of $10.54 per share, with a total value of $10,571.62. Following the completion of the acquisition, the insider directly owned 4,500 shares of the company's stock, valued at $47,430. This represents a 28.68% increase in th…

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

MarketBeat broke the news in Sioux Falls, United States on Saturday, November 14, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
News
Feed Dots Icon
For You
Search Icon
Search
Blindspot LogoBlindspotLocal